Ā | ITT covariate model | Standardised effect at 12 monthsā | CACE covariate model | Standardised effect at 12 monthsā” | ||
---|---|---|---|---|---|---|
Ā | Mean treatment difference (95% CI)* | p value | Mean treatment difference (95% CI)ā | p value | ||
Roland Morris Questionnaire (points) | ||||||
3Ā months | 1.1 (0.39, 1.77) | 0.002 | .. | 1.1 (0.04, 2.22) | 0.042 | .. |
6Ā months | 1.4 (0.72, 2.16) | <0.001 | .. | 1.9 (0.87, 2.98) | <0.001 | .. |
12Ā months | 1.3 (0.55, 2.07) | 0.001 | 0.31 | 1.6 (0.51, 2.74) | 0.004 | 0.43 |
Modified Von Korff disability (%) | ||||||
3Ā months | 4.6 (0.75, 8.52) | 0.029 | .. | 5.4 (-0.38, 11.15) | 0.067 | .. |
6Ā months | 8.3 (4.32, 12.35) | <0.001 | .. | 11.1 (5.30, 16.83) | <0.001 | .. |
12Ā months | 8.6 (4.58, 12.64) | <0.001 | 0.42 | 12.1 (6.07, 18.17) | <0.001 | 0.60 |
Modified Von Korff pain (%) | ||||||
3Ā months | 6.9 (3.53, 10.29) | <0.001 | .. | 8.8 (3.84, 13.82) | 0.001 | .. |
6Ā months | 8.2 (4.48, 11.97) | <0.001 | .. | 11.2 (5.89, 16.61) | <0.001 | .. |
12Ā months | 7.00 (3.26, 10.74) | <0.001 | 0.37 | 10.4 (4.64, 16.10) | <0.001 | 0.60 |
EQ-5D | ||||||
3Ā months | 0.08 (0.033, 0.117) | <0.001 | .. | 0.09 (0.020, 0.161) | 0.012 | .. |
6Ā months | 0.04 (-0.007, 0.080) | 0.098 | .. | 0.06 (-0.011, 0.121) | 0.102 | .. |
12Ā months | 0.05 (0.010, 0.097) | 0.015 | 0.13 | 0.07 (0.008, 0.141) | 0.029 | 0.36 |